Skip to main content
Clinical Trials/NCT05729009
NCT05729009RecruitingNot Applicable

The Evolution of Systemic Microvascular Reactivity in Heart Transplant Patients

National Institute of Cardiology, Laranjeiras, Brazil2 sites in 1 country31 target enrollmentStarted: October 1, 2022Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
31
Locations
2
Primary Endpoint
Baseline and post-iontophoresis of acetylcholine endothelium-dependent skin microvascular reactivity

Study Overview

Brief Summary

The evolution of systemic microvascular reactivity may aid in the comprehension of cardiovascular physiology in heart transplantation patients, and possibly suggest the non-invasive evaluation of skin microcirculation as an ancillary tool in the clinical evaluation of these patients.

Detailed Description

Introduction

Systemic microvascular reactivity (MR) is an essential component of cardiovascular physiology, being studied through non-invasive techniques in readily accessible body regions, such as the skin surface. Heart transplant (HT) is a treatment considered to selected patients, with advanced heart failure. The main cause of long-term mortality after HT is graft vascular disease (GVD), a condition which starts with endothelial dysfunction. To know the evolution of systemic MR in patients subjected to HT can help to find prognostic factors. Objective: The present study aims to perform the prospective evaluation of systemic MR in adult patients, before and two years after HT, at a quaternary hospital, correlating the findings with clinical variables. Methods: Systemic MR will be evaluated in the skin of the forearm using laser speckle contrast imaging with acetylcholine (ACh) iontophoresis, followed by postocclusive reactive hyperemia (PORH), before and after HT. Measurements will be correlated to patient clinical profile, hemodynamic and echocardiographic data. Expected results: The evolution of systemic MR may aid in the comprehension of cardiovascular physiology in HT patients, and possibly suggest the non-invasive evaluation of skin microcirculation as an ancillary tool in the clinical evaluation of these patients.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • capability to understand the objectives of the research and to fulfill the Term of Consent

Exclusion Criteria

  • Pregnancy, acute infection diagnosis, use of circulatory assistance devices

Arms & Interventions

heart transplantation

Intervention: skin microvascular reactivity (Diagnostic Test)

Outcomes

Primary Outcomes

Baseline and post-iontophoresis of acetylcholine endothelium-dependent skin microvascular reactivity

Time Frame: Microvascular reactivity will be evaluated 20-minute rest in the supine position in a temperature-controlled room.

Evaluation of systemic microvascular reactivity induced by endothelium-dependent agents. Microvascular reactivity will be evaluated using a non-invasive and operator -independent methodology, named laser speckle contrast imaging, coupled with skin iontophoresis of vasodilator agents. Cutaneous microvascular flow will be measured in arbitrary perfusion units, divided by mean arterial pressure, to yield cutaneous vascular conductance.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
National Institute of Cardiology, Laranjeiras, Brazil
Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

Eduardo Tibirica, MD, PhD

Principal Investigator

National Institute of Cardiology, Laranjeiras, Brazil

Study Sites (2)

Loading locations...

Similar Trials